Back to JNJ

JOHNSON & JOHNSON Stockholders' Equity 2006-2026 | JNJ

Beta

What is stockholders' equity?

Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.

What is JOHNSON & JOHNSON's current stockholders' equity?

JOHNSON & JOHNSON (JNJ) annual stockholders' equity for 2025 was $81.54B, a 14.06% increase from 2024. JOHNSON & JOHNSON stockholders' equity for the quarter ending March 29, 2026 was $81.19B.

What was JOHNSON & JOHNSON's stockholders' equity in 2024?

JOHNSON & JOHNSON annual stockholders' equity for 2024 was $71.49B, a 6.92% decline from 2023.

What was JOHNSON & JOHNSON's stockholders' equity in 2023?

JOHNSON & JOHNSON annual stockholders' equity for 2023 was $76.80B, a 3.76% increase from 2022.

What is JOHNSON & JOHNSON's 4-year stockholders' equity CAGR?

JOHNSON & JOHNSON stockholders' equity grew at a compound annual growth rate (CAGR) of 6.55% from FY2021 to FY2025, going from $63.28B to $81.54B over 4 years.

Stockholders' Equity History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+6.5%
FY2019
$59.47B
FY2025
$81.54B
0607081011121314161718192122232425
5 years selected
Stockholders' Equity History
PeriodValueChangeSource
FY2025$81.54B+14.1%10-K
FY2024$71.49B-6.9%10-K
FY2023$76.80B+3.8%10-K
FY2022$74.02B+17.0%10-K
FY2021$63.28B+6.4%10-K
FY2019$59.47B-0.5%10-K
FY2018$59.75B-0.7%10-K
FY2017$60.16B-15.4%10-K
FY2016$71.15B+2.0%10-K
FY2014$69.75B-5.8%10-K
FY2013$74.05B+14.2%10-K
FY2012$64.83B+14.6%10-K
FY2011$56.58B+11.8%10-K
FY2010$50.59B+19.0%10-K
FY2008$42.51B-1.9%10-K
FY2007$43.32B+10.2%10-K
FY2006$39.32B-10-K
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →